BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Charidimou A, Martinez-Ramirez S, Shoamanesh A, Oliveira-Filho J, Frosch M, Vashkevich A, Ayres A, Rosand J, Gurol ME, Greenberg SM, Viswanathan A. Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease phenotypes. Neurology 2015;84:1206-12. [PMID: 25716356 DOI: 10.1212/WNL.0000000000001398] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Jo S, Cheong E, Kim N, Oh JS, Shim WH, Kim H, Lee SJ, Lee Y, Oh M, Kim JS, Kim BJ, Roh JH, Kim SJ, Lee J, Zhu Y. Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy. JAD 2022. [DOI: 10.3233/jad-215094] [Reference Citation Analysis]
2 Moore BD, Levites Y, Xu G, Hampton H, Adamo MF, Croft CL, Futch HS, Moran C, Fromholt S, Janus C, Prokop S, Dickson D, Lewis J, Giasson BI, Golde TE, Borchelt DR. Soluble brain homogenates from diverse human and mouse sources preferentially seed diffuse Aβ plaque pathology when injected into newborn mouse hosts. Free Neuropathol 2022;3:9. [PMID: 35494163 DOI: 10.17879/freeneuropathology-2022-3766] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Yong-Peng Yu, Zheng YL. Relationship between Urinary AD7c-NTP with Cerebral Microbleeds Based on APOE Genotype. Biomed Res Int 2021;2021:3928060. [PMID: 34660786 DOI: 10.1155/2021/3928060] [Reference Citation Analysis]
4 Haußmann R, Homeyer P, Donix M, Linn J. [Current findings on the coincidence of cerebral amyloid angiopathy and Alzheimer's disease]. Nervenarzt 2021. [PMID: 34652483 DOI: 10.1007/s00115-021-01213-x] [Reference Citation Analysis]
5 Graff-Radford J, Lesnick TG, Mielke MM, Constantopoulos E, Rabinstein AA, Przybelski SA, Vemuri P, Botha H, Jones DT, Ramanan VK, Petersen RC, Knopman DS, Boeve BF, Murray ME, Dickson DW, Jack CR, Kantarci K, Reichard RR. Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes. J Alzheimers Dis 2021;81:113-22. [PMID: 33720897 DOI: 10.3233/JAD-201536] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Inoue Y, Ando Y, Misumi Y, Ueda M. Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy. Int J Mol Sci 2021;22:3869. [PMID: 33918041 DOI: 10.3390/ijms22083869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sporns PB, Psychogios MN, Boulouis G, Charidimou A, Li Q, Fainardi E, Dowlatshahi D, Goldstein JN, Morotti A. Neuroimaging of Acute Intracerebral Hemorrhage. J Clin Med 2021;10:1086. [PMID: 33807843 DOI: 10.3390/jcm10051086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Raposo N, Zanon Zotin MC, Schoemaker D, Xiong L, Fotiadis P, Charidimou A, Pasi M, Boulouis G, Schwab K, Schirmer MD, Etherton MR, Gurol ME, Greenberg SM, Duering M, Viswanathan A. Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy. AJNR Am J Neuroradiol 2021;42:875-81. [PMID: 33664113 DOI: 10.3174/ajnr.A7042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Li Z, Shue F, Zhao N, Shinohara M, Bu G. APOE2: protective mechanism and therapeutic implications for Alzheimer's disease. Mol Neurodegener 2020;15:63. [PMID: 33148290 DOI: 10.1186/s13024-020-00413-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
10 Lee JS, Lee H, Park S, Choe Y, Park YH, Cheon BK, Hahn A, Ossenkoppele R, Kim HJ, Kim S, Yoo H, Jang H, Cho SH, Kim SJ, Kim JP, Jung YH, Park KC, DeCarli C, Weiner MW, Na DL, Seo SW. Association between APOE ε2 and Aβ burden in patients with Alzheimer- and vascular-type cognitive impairment. Neurology 2020;95:e2354-65. [PMID: 32928967 DOI: 10.1212/WNL.0000000000010811] [Reference Citation Analysis]
11 Chernick D, Zhong R, Li L. The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease. Biomolecules 2020;10:E1276. [PMID: 32899606 DOI: 10.3390/biom10091276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
12 Xia Y, Prokop S, Gorion KM, Kim JD, Sorrentino ZA, Bell BM, Manaois AN, Chakrabarty P, Davies P, Giasson BI. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies. Acta Neuropathol Commun 2020;8:88. [PMID: 32571418 DOI: 10.1186/s40478-020-00967-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
13 Biffi A, Urday S, Kubiszewski P, Gilkerson L, Sekar P, Rodriguez-Torres A, Bettin M, Charidimou A, Pasi M, Kourkoulis C, Schwab K, DiPucchio Z, Behymer T, Osborne J, Morgan M, Moomaw CJ, James ML, Greenberg SM, Viswanathan A, Gurol ME, Worrall BB, Testai FD, McCauley JL, Falcone GJ, Langefeld CD, Anderson CD, Kamel H, Woo D, Sheth KN, Rosand J. Combining Imaging and Genetics to Predict Recurrence of Anticoagulation-Associated Intracerebral Hemorrhage. Stroke 2020;51:2153-60. [PMID: 32517581 DOI: 10.1161/STROKEAHA.120.028310] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
14 Shindo A, Ishikawa H, Ii Y, Niwa A, Tomimoto H. Clinical Features and Experimental Models of Cerebral Small Vessel Disease. Front Aging Neurosci 2020;12:109. [PMID: 32431603 DOI: 10.3389/fnagi.2020.00109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Pongpitakmetha T, Fotiadis P, Pasi M, Boulouis G, Xiong L, Warren AD, Schwab KM, Rosand J, Gurol ME, Greenberg SM, Viswanathan A, Charidimou A. Cortical superficial siderosis progression in cerebral amyloid angiopathy: Prospective MRI study. Neurology 2020;94:e1853-65. [PMID: 32284360 DOI: 10.1212/WNL.0000000000009321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
16 Baldacci F, Mazzucchi S, Della Vecchia A, Giampietri L, Giannini N, Koronyo-Hamaoui M, Ceravolo R, Siciliano G, Bonuccelli U, Elahi FM, Vergallo A, Lista S, Giorgi FS, Hampel H. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases. Expert Rev Mol Diagn 2020;20:421-41. [PMID: 32066283 DOI: 10.1080/14737159.2020.1731306] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
17 Kulesh AA, Gorst NK, Kuzina NV, Drobakha VE, Shestakov VV, Karakulova YV. Amyloid angiitis and progressive cortical superficial siderosis as aggressive phenotypes of cerebral amyloid angiopathy: principles of rational management. РНЖ 2020;24:29-38. [DOI: 10.30629/2658-7947-2019-24-6-29-38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yost M, Fiebelkorn CA, Rabinstein AA, Klaas J, Aakre JA, Brown RD Jr, Mielke MM, Knopman DS, Lowe V, Petersen RC, Jack CR Jr, Vemuri P, Graff-Radford J. Incidence of Convexal Subarachnoid Hemorrhage in the Elderly: The Mayo Clinic Study of Aging. J Stroke Cerebrovasc Dis 2019;28:104451. [PMID: 31668581 DOI: 10.1016/j.jstrokecerebrovasdis.2019.104451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Belloy ME, Napolioni V, Greicius MD. A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward. Neuron 2019;101:820-38. [PMID: 30844401 DOI: 10.1016/j.neuron.2019.01.056] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 41.7] [Reference Citation Analysis]
20 Charidimou A, Zonneveld HI, Shams S, Kantarci K, Shoamanesh A, Hilal S, Yates PA, Boulouis G, Na HK, Pasi M, Biffi A, Chai YL, Chong JR, Wahlund LO, Clifford JR, Chen C, Gurol ME, Goldstein JN, Na DL, Barkhof F, Seo SW, Rosand J, Greenberg SM, Viswanathan A. APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms. Neurology 2019;93:e358-71. [PMID: 31243071 DOI: 10.1212/WNL.0000000000007818] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
21 Das AS, Regenhardt RW, Vernooij MW, Blacker D, Charidimou A, Viswanathan A. Asymptomatic Cerebral Small Vessel Disease: Insights from Population-Based Studies. J Stroke 2019;21:121-38. [PMID: 30991799 DOI: 10.5853/jos.2018.03608] [Cited by in Crossref: 32] [Cited by in F6Publishing: 46] [Article Influence: 10.7] [Reference Citation Analysis]
22 Camacho J, Moliné T, Bonaterra-Pastra A, Ramón Y Cajal S, Martínez-Sáez E, Hernández-Guillamon M. Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy. Front Neurol 2019;10:187. [PMID: 30918495 DOI: 10.3389/fneur.2019.00187] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
23 You Y, Perkins A, Cisternas P, Muñoz B, Taylor X, You Y, Garringer HJ, Oblak AL, Atwood BK, Vidal R, Lasagna-Reeves CA. Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy. Acta Neuropathol Commun 2019;7:26. [PMID: 30808415 DOI: 10.1186/s40478-019-0680-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
24 Endo Y, Hasegawa K, Nomura R, Arishima H, Kikuta KI, Yamashita T, Inoue Y, Ueda M, Ando Y, Wilson MR, Hamano T, Nakamoto Y, Naiki H. Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy. Acta Neuropathol Commun 2019;7:12. [PMID: 30691533 DOI: 10.1186/s40478-019-0662-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
25 Pasi M, Charidimou A, Boulouis G, Fotiadis P, Morotti A, Xiong L, Marini S, Ayres A, Frosch MP, Goldstein JN, Rosand J, Gurol ME, Greenberg SM, Viswanathan A. Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage. J Neurol 2019;266:625-30. [PMID: 30617995 DOI: 10.1007/s00415-018-09177-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 Cooperman SS, Shah AK, Rajamani K. Amyloid spells. Neurol Clin Pract 2019;9:e17-8. [PMID: 31041142 DOI: 10.1212/CPJ.0000000000000579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
27 Lamar M, Yu L, Rubin LH, James BD, Barnes LL, Farfel JM, Gaiteri C, Buchman AS, Bennett DA, Schneider JA. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement 2019;15:258-66. [PMID: 30321502 DOI: 10.1016/j.jalz.2018.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
28 Brothers HM, Gosztyla ML, Robinson SR. The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease. Front Aging Neurosci 2018;10:118. [PMID: 29922148 DOI: 10.3389/fnagi.2018.00118] [Cited by in Crossref: 116] [Cited by in F6Publishing: 137] [Article Influence: 29.0] [Reference Citation Analysis]
29 Charidimou A, Friedrich JO, Greenberg SM, Viswanathan A. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis. Neurology 2018;90:e754-62. [PMID: 29386280 DOI: 10.1212/WNL.0000000000005030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
30 Charidimou A, Boulouis G, Roongpiboonsopit D, Auriel E, Pasi M, Haley K, van Etten ES, Martinez-Ramirez S, Ayres A, Vashkevich A, Schwab KM, Goldstein JN, Rosand J, Viswanathan A, Greenberg SM, Gurol ME. Cortical superficial siderosis multifocality in cerebral amyloid angiopathy: A prospective study. Neurology 2017;89:2128-35. [PMID: 29070669 DOI: 10.1212/WNL.0000000000004665] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 9.6] [Reference Citation Analysis]
31 Pichler M, Vemuri P, Rabinstein AA, Aakre J, Flemming KD, Brown RD Jr, Kumar N, Kantarci K, Kremers W, Mielke MM, Knopman DS, Jack CR Jr, Petersen RC, Lowe V, Graff-Radford J. Prevalence and Natural History of Superficial Siderosis: A Population-Based Study. Stroke 2017;48:3210-4. [PMID: 29070715 DOI: 10.1161/STROKEAHA.117.018974] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
32 Inoue Y, Ueda M, Tasaki M, Takeshima A, Nagatoshi A, Masuda T, Misumi Y, Kosaka T, Nomura T, Mizukami M, Matsumoto S, Yamashita T, Takahashi H, Kakita A, Ando Y. Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy. Acta Neuropathol 2017;134:605-17. [PMID: 28478503 DOI: 10.1007/s00401-017-1720-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
33 Charidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP, Viswanathan A, Greenberg SM. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain 2017;140:1829-50. [PMID: 28334869 DOI: 10.1093/brain/awx047] [Cited by in Crossref: 169] [Cited by in F6Publishing: 196] [Article Influence: 33.8] [Reference Citation Analysis]
34 Banerjee G, Carare R, Cordonnier C, Greenberg SM, Schneider JA, Smith EE, Buchem MV, Grond JV, Verbeek MM, Werring DJ. The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. J Neurol Neurosurg Psychiatry 2017;88:982-94. [PMID: 28844070 DOI: 10.1136/jnnp-2016-314697] [Cited by in Crossref: 120] [Cited by in F6Publishing: 107] [Article Influence: 24.0] [Reference Citation Analysis]
35 Qi XM, Ma JF. The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets. Transl Neurodegener 2017;6:22. [PMID: 28824801 DOI: 10.1186/s40035-017-0091-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
36 Samarasekera N, Rodrigues MA, Toh PS, Al-Shahi R. Imaging features of intracerebral hemorrhage with cerebral amyloid angiopathy: Systematic review and meta-analysis. PLoS One 2017;12:e0180923. [PMID: 28700676 DOI: 10.1371/journal.pone.0180923] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
37 Charidimou A, Martinez-Ramirez S, Reijmer YD, Oliveira-Filho J, Lauer A, Roongpiboonsopit D, Frosch M, Vashkevich A, Ayres A, Rosand J, Gurol ME, Greenberg SM, Viswanathan A. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation. JAMA Neurol 2016;73:994-1001. [PMID: 27366898 DOI: 10.1001/jamaneurol.2016.0832] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 12.8] [Reference Citation Analysis]
38 Boulouis G, van Etten ES, Charidimou A, Auriel E, Morotti A, Pasi M, Haley KE, Brouwers HB, Ayres AM, Vashkevich A, Jessel MJ, Schwab KM, Viswanathan A, Greenberg SM, Rosand J, Goldstein JN, Gurol ME. Association of Key Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease With Hematoma Volume and Expansion in Patients With Lobar and Deep Intracerebral Hemorrhage. JAMA Neurol 2016;73:1440-7. [PMID: 27723863 DOI: 10.1001/jamaneurol.2016.2619] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
39 Farid K, Charidimou A, Baron JC. Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update. Neuroimage Clin 2017;15:247-63. [PMID: 28560150 DOI: 10.1016/j.nicl.2017.05.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
40 Charidimou A, Boulouis G, Xiong L, Jessel MJ, Roongpiboonsopit D, Ayres A, Schwab KM, Rosand J, Gurol ME, Greenberg SM, Viswanathan A. Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2017;88:1607-14. [PMID: 28356458 DOI: 10.1212/WNL.0000000000003866] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 8.6] [Reference Citation Analysis]
41 Wilson D, Hostettler IC, Ambler G, Banerjee G, Jäger HR, Werring DJ. Convexity subarachnoid haemorrhage has a high risk of intracerebral haemorrhage in suspected cerebral amyloid angiopathy. J Neurol 2017;264:664-73. [PMID: 28154972 DOI: 10.1007/s00415-017-8398-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
42 Boulouis G, Charidimou A, Jessel MJ, Xiong L, Roongpiboonsopit D, Fotiadis P, Pasi M, Ayres A, Merrill ME, Schwab KM, Rosand J, Gurol ME, Greenberg SM, Viswanathan A. Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage. Neurology 2017;88:878-84. [PMID: 28130469 DOI: 10.1212/WNL.0000000000003655] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
43 Finch CE, Shams S. Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice. Trends Neurosci 2016;39:625-37. [PMID: 27546867 DOI: 10.1016/j.tins.2016.07.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
44 Tai LM, Thomas R, Marottoli FM, Koster KP, Kanekiyo T, Morris AW, Bu G. The role of APOE in cerebrovascular dysfunction. Acta Neuropathol 2016;131:709-23. [PMID: 26884068 DOI: 10.1007/s00401-016-1547-z] [Cited by in Crossref: 107] [Cited by in F6Publishing: 96] [Article Influence: 17.8] [Reference Citation Analysis]
45 Charidimou A, Ni J, Martinez-Ramirez S, Vashkevich A, Ayres A, Rosand J, Gurol EM, Greenberg SM, Viswanathan A. Cortical Superficial Siderosis in Memory Clinic Patients: Further Evidence for Underlying Cerebral Amyloid Angiopathy. Cerebrovasc Dis 2016;41:156-62. [PMID: 26751369 DOI: 10.1159/000442299] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
46 van Veluw SJ, Biessels GJ, Bouvy WH, Spliet WG, Zwanenburg JJ, Luijten PR, Macklin EA, Rozemuller AJ, Gurol ME, Greenberg SM, Viswanathan A, Martinez-Ramirez S. Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces. J Cereb Blood Flow Metab 2016;36:576-80. [PMID: 26661250 DOI: 10.1177/0271678X15620434] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
47 Brenowitz WD, Nelson PT, Besser LM, Heller KB, Kukull WA. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes. Neurobiol Aging 2015;36:2702-8. [PMID: 26239176 DOI: 10.1016/j.neurobiolaging.2015.06.028] [Cited by in Crossref: 57] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]